Stakeholders

PALLAS will build a safe and advanced production facility that will become the world’s largest producer of radioisotopes for nuclear medicine and enable research into nuclear technology. Not only is this important to PALLAS, but also to parties from its direct and indirect environment.

Nuclear medicine - Wim Oyen

The arrival of the new reactor will attract all sorts of knowledge institutions and nuclear researchers, which can greatly contribute to the economy.

We asked Wim Oyen, professor of Nuclear Medicine Humanitas University and Radboudumc Nijmegen, nuclear medicine physician Rijnstate Arnhem and president of the European Association of Nuclear Medicine, his view on PALLAS. 'My European colleagues regularly ask me about the progress of the PALLAS-reactor....

Other stakeholders